West Pharmaceutical Services 과거 수익 실적
과거 기준 확인 2/6
West Pharmaceutical Services has been growing earnings at an average annual rate of 13.8%, while the Life Sciences industry saw earnings growing at 17% annually. Revenues have been growing at an average rate of 9.8% per year. West Pharmaceutical Services's return on equity is 18.2%, and it has net margins of 17.4%.
주요 정보
13.8%
수익 성장률
13.8%
EPS 성장률
| Life Sciences 산업 성장 | 12.9% |
| 매출 성장률 | 9.8% |
| 자기자본 수익률 | 18.2% |
| 순이익 | 17.4% |
| 최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
수익 및 비용 분석
West Pharmaceutical Services 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Sep 24 | 2,876 | 500 | 342 | 69 |
| 30 Jun 24 | 2,877 | 525 | 349 | 70 |
| 31 Mar 24 | 2,929 | 569 | 355 | 69 |
| 31 Dec 23 | 2,950 | 593 | 354 | 68 |
| 30 Sep 23 | 2,927 | 559 | 299 | 66 |
| 30 Jun 23 | 2,866 | 519 | 326 | 63 |
| 31 Mar 23 | 2,884 | 552 | 319 | 61 |
| 31 Dec 22 | 2,887 | 586 | 316 | 59 |
| 30 Sep 22 | 2,909 | 631 | 377 | 56 |
| 30 Jun 22 | 2,929 | 686 | 352 | 56 |
| 31 Mar 22 | 2,881 | 684 | 362 | 55 |
| 31 Dec 21 | 2,832 | 662 | 356 | 53 |
| 30 Sep 21 | 2,681 | 613 | 340 | 52 |
| 30 Jun 21 | 2,523 | 519 | 310 | 51 |
| 31 Mar 21 | 2,326 | 423 | 308 | 48 |
| 31 Dec 20 | 2,147 | 346 | 301 | 47 |
| 30 Sep 20 | 2,037 | 312 | 291 | 44 |
| 30 Jun 20 | 1,945 | 286 | 297 | 41 |
| 31 Mar 20 | 1,888 | 261 | 277 | 40 |
| 31 Dec 19 | 1,840 | 242 | 273 | 39 |
| 30 Sep 19 | 1,792 | 230 | 262 | 39 |
| 30 Jun 19 | 1,767 | 229 | 259 | 39 |
| 31 Mar 19 | 1,745 | 219 | 258 | 41 |
| 31 Dec 18 | 1,717 | 207 | 256 | 40 |
| 30 Sep 18 | 1,711 | 155 | 257 | 40 |
| 30 Jun 18 | 1,677 | 151 | 256 | 39 |
| 31 Mar 18 | 1,627 | 133 | 248 | 38 |
| 31 Dec 17 | 1,599 | 151 | 243 | 39 |
| 30 Sep 17 | 1,566 | 190 | 245 | 39 |
| 30 Jun 17 | 1,544 | 176 | 242 | 39 |
| 31 Mar 17 | 1,535 | 182 | 243 | 38 |
| 31 Dec 16 | 1,509 | 144 | 238 | 37 |
| 30 Sep 16 | 1,487 | 138 | 241 | 37 |
| 30 Jun 16 | 1,454 | 102 | 238 | 37 |
| 31 Mar 16 | 1,426 | 85 | 246 | 36 |
| 31 Dec 15 | 1,400 | 96 | 243 | 34 |
| 30 Sep 15 | 1,390 | 94 | 240 | 32 |
| 30 Jun 15 | 1,401 | 123 | 241 | 33 |
| 31 Mar 15 | 1,411 | 133 | 228 | 35 |
| 31 Dec 14 | 1,421 | 127 | 229 | 37 |
| 30 Sep 14 | 1,414 | 119 | 230 | 39 |
| 30 Jun 14 | 1,400 | 115 | 230 | 39 |
| 31 Mar 14 | 1,376 | 108 | 232 | 39 |
| 31 Dec 13 | 1,368 | 112 | 235 | 38 |
양질의 수익: WST * has high quality earnings.
이익 마진 증가: WST *'s current net profit margins (17.4%) are lower than last year (19.1%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: WST *'s earnings have grown by 13.8% per year over the past 5 years.
성장 가속화: WST *'s has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
수익 대 산업: WST * had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Life Sciences industry average (-5.7%).
자기자본 수익률
높은 ROE: WST *'s Return on Equity (18.2%) is considered low.